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Background Minimally invasive alternatives to surgical closure of cardiac perforations are a recognized need, especially in critic-
ally ill patients in whom predicted surgical mortality is prohibitive. To the best of our knowledge, this is the first
reported case of an iatrogenic left atrium (LA) puncture closed with a plug-based vascular closure device (VCD).
...................................................................................................................................................................................................
Case summary During a palliative right-sided thoracentesis on a 73-year-old woman, with end-stage heart failure due to rheumatic
valvular heart disease, an accidental puncture and insertion of a central venous catheter into an aneurysmatic LA
occurred. This complication was successfully managed percutaneously, under transthoracic echocardiographic guid-
ance, after cardiac computed tomography planning, using a plug-based VCD.
...................................................................................................................................................................................................
Discussion This case demonstrates the possible utility of plug-based devices for iatrogenic LA perforation closure, when surgi-
cal risk is deemed prohibitive.
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Introduction
There is a recognized need for less invasive alternatives to over-
come the high mortality associated with surgical closure of cardiac
perforations in high-risk patients. Several non-surgical approaches,
namely percutaneous techniques using Angio-SealVR , 1–4 fibrin glue,
5 AmplatzerTM 6 devices, and expectant management 7 have been
recently reported as compassionate treatments. Moreover, these
may be a reasonable option as bridge to surgery in patients who
are at risk of sudden haemodynamic collapse.
Here, we report the first case, in literature, of percutaneous clos-
ure of an accidental iatrogenic left atrium (LA) perforation with a vas-
cular closure device (VCD).
Learning points
• Less invasive alternatives for the management of cardiac punctures in high-risk patients should be an option.
• Vascular closure devices, when possible, can be a successful and safe alternative for heart chambers perforations.
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A 73-year-old woman patient with long-standing combined mitral
and aortic mechanical prosthesis due to rheumatic valvular heart dis-
ease was admitted to our centre for heart failure (HF). Her past med-
ical history was remarkable for type 2 diabetes mellitus,
hypertension, permanent atrial fibrillation, type II pulmonary hyper-
tension, cardiac cirrhosis, and haematologic disorder [anaemia (base-
line haemoglobin 10 g/dL) and leukopenia]. Since 2012, HF
progressively ensued related to aortic prosthetic valve dysfunction,
secondary to pannus. In 2015, she was refused for surgery for pro-
hibitively high expected surgical risk (EuroSCORE II 14%), anatomic
complexity, comorbidities, and frailty.
On July 2019, she was admitted for acute HF, with dyspnoea at
rest, orthopnoea, signs of pulmonary congestion at physical examin-
ation and had a systolic blood pressure of100 mmHg and irregular
tachycardia (110 b.p.m.). Chest X-ray, also, revealing an extensive
bilateral pleural effusion ( Figure 1). Previously to admission, she was
medicated with furosemide 40 mg bid, spironolactone 50 mg id,
metolazone 5 mg three times per week, valsartan 80 mg id, warfarin,
digoxin 0.125 mg id, and oral antidiabetic drugs. Transthoracic echo-
cardiography (TTE) showed a left ventricle ejection fraction of 52%
(calculated by modified Simpson’s rule) (Video 1), a mean aortic pros-
thesis’ gradient of 40 mmHg, an aortic valve velocity ratio of 0.18, and
an aneurysmatic LA (indexed LA volume of 688 mL/m2) ( Figure 2).
Despite increasing doses of intravenous diuretics (maximum fur-
osemide infusion: furosemide 24 mg/h), there was no clinical
improvement, impending respiratory failure ensued and the patient
was started on non-invasive ventilation, within 48 h. Accordingly, a
right-sided therapeutic thoracentesis, for symptomatic relief, was
planned and performed by a cardiothoracic surgeon, after the patient
had consented.
A 6 Fr single lumen venous central catheter was inserted in the
mid-axillary line into the sixth right intercostal space, under ultra-
sound guidance using Seldinger technique. After an initial 900 mL of
haematic fluid drainage, the patient became diaphoretic, with gradual
hypotension and tachycardia. Transthoracic echocardiography with
.................................................................................................
Time Events
1984 Rheumatic valvular heart disease diagnosis: severe
mitral stenosis and moderate aortic stenosis
1986 Implantation of a mitral and aortic mechanical
prosthesis
2012 New York Heart Association (NYHA) Class II symp-
toms owing to pannus of aortic mechanical
prosthesis
2015 NYHA Class III symptoms and transprosthetic aortic
mean gradient of 34 mmHg
Refused for surgery due to a high surgical risk score
(EuroSCORE II 14%)
2015–2019 Two hospitalizations for congestive heart failure (HF)
managed with intravenous diuretics
2019 July Hospitalization for congestive HF, refractory to intra-
venous diuretics, with severe dyspnoea and large
pleural effusion
Iatrogenic left atrium (LA) perforation during thora-
centesis, for symptomatic relief
Successful percutaneous closure of LA accidental punc-
ture with a vascular closure device
Figure 1 Chest X-ray with cardiomegaly and extensive bilateral
pleural effusion.
Video 1 Baseline transthoracic echocardiography at admission:
four-chamber view; axial view at papillary muscle level; left ventricle
focused view; right ventricle focused view.







































agitated saline contrast injection through the catheter unveiled LA
perforation (Video 2). Invasive ventilation was required for haemo-
dynamic and respiratory stabilization and intravenous fluid replace-
ment was initiated. Auto-transfusion of the aspirated blood was
performed and on-going oral anticoagulation was neutralized with
prothrombin complex [International Normalized Ratio (INR) value
before thoracentesis was 2.2].
Cardiac computed tomography (CT) confirmed the aneurysmatic
LA (maximum LA volume: 1107 mL) and revealed the close proxim-
ity of the LA wall with the right thoracic chest wall (21 mm) (
Figure 3). Multidisciplinary team discussion, with interventional cardi-
ologists and clinical cardiologists, cardiac surgeons, and anaesthetists
deemed the patient at high surgical risk, and it was decided to per-
form a percutaneous LA closure with off-label use of the Angio-SealVR
VCD, with on-site surgical backup.
A short 0.035 guide-wire was advanced through the thoracentesis
drain into the LA and the sheath was removed. An 8 Fr Angio-SealVR
closure device was inserted over the guide-wire and anchored in the
LA with the standard technique, under TTE guidance. Thereafter, the
collagen plug was successfully deployed, allowing complete perfor-
ation closure. Other than guiding the procedure, TTE was paramount
to avoid any interaction with mechanical mitral prosthesis, to confirm
adequate device positioning and the lack of residual flow by colour
Doppler analysis, at the site of LA puncture. Serial TTEs (Video 3)
over the following hours and cardiac CT after 7 days ( Figure 4) con-
firmed the sustained correct positioning of the device with minimal
residual pericardial effusion, despite of anticoagulation with adjusted
unfractionated heparin to prevent mitral thrombosis. Patient’s
haemodynamic improvement pursued and inotropes were weaned
off. However, weaning from mechanical ventilation was not possible
given the previous advanced health condition, clinical status progres-
sively deteriorate and the patient died due to sepsis, 11 days after the
Angio-SealVR closure.
Discussion
Congestive HF is currently the main cause of pleural effusion. 8
Persistent moderate or severe pleural effusion has been shown to be
associated with increased morbidity and mortality. Thoracentesis is
performed for either diagnostic and/or therapeutic purposes.
Palliative thoracentesis is advocated for extensive pleural effusions in
terminal HF, mainly for quality-of-life improvement and effective
symptomatic relief in end-of-life care.
Complications of thoracentesis are seldom observed. Bleeding
(including haemothorax) has been reported in approximately 0–
2% of patients undergoing thoracentesis with uncorrected coagula-
tion. 9 Cardiac injury during chest drain placement is even rarer, but
catastrophic complication, with only 10 cases being reported to date.
10,11 Most of these were related to anatomic distortion, as in post-
pneumonectomy, extreme kyphoscoliosis, and cardiomegaly.
Similarly, to these previous reports, our patient had marked cardio-
megaly due to an aneurysmatic LA and passive lung atelectasis. In
complex cases such as this, CT-guided thoracentesis, in addition to
TTE control during the procedure, should probably be proposed be-
forehand as a means to avoid iatrogenic punctures.
To the best of our knowledge, this is the second case in the litera-
ture of LA iatrogenic perforation during chest drainage 12 and the first
case of successful percutaneous closure with a VCD of LA.
Iatrogenic cardiac perforation is potentially fatal complication.
Cardiac perforation may complicate with cardiac tamponade, requir-
ing emergent pericardial drainage or surgery with repair of the defect
Figure 2 Measurement of left atrium volume from biplane method of discs (modified Simpson’s rule) using apical four-chamber (A) and apical two-
chamber (B) views at maximum volume; subcostal view of aneurysmatic left atrium, right atrium, and inferior vena cava (C).
Video 2 Agitated saline transthoracic echocardiography testing
confirming the left atrium perforation.


















..as standard-of-care. However, pericardiocentesis is not a definitive
solution when heart perforation occurs by venous catheters, with a
mortality rate approaching 62%. 2 Similarly, the surgery may not be
an acceptable option for high-risk surgical patients, in whom mortality
rate has been reported to be as high as 85%. 2 Minimally invasive pro-
cedures could mitigate such high mortality.
Vascular closure device is a proven alternative to mechanical fem-
oral compression after endovascular procedures. Their off-label use
is rather uncommon and usually restricted for atypical vascular sites.
13–15 Recently, successful use of this devices in right heart punctures
(atrium and ventricle) were reported. 1–4 However, to the best of
our knowledge, left chamber closure has not been performed.
Indeed, approach to the left chambers are predictively more chal-
lenging, given the higher filling and downstream pressures. 4
Angio-sealVR VCD consists of a resorbable anchor (tethered by a
polymer filament) which is placed in the intravascular compartment,
Figure 3 Cardiac computed tomography was essential for the precise planning of the percutaneous procedure confirming the volume size of the
left atrium and the distance between thoracic chest wall and left atrium wall (21 mm).
Video 3 Transthoracic echocardiography showing the correct pos-
ition of the plug device into the left atrium wall, with no pericardial effu-
sion increase after 2 h of the procedure.
Figure 4 Cardiac computed tomography 7 days after the deploy-
ment of the Angio-SealVR .

































































..over which a collagen plug is applied, resting in the extravascular space.
When closing the cardiac perforation, the resorbable anchor is released
inside the cardiac chamber and the collagen plug remains on the heart’s
surface. 16 In this case, the measurements and the anatomical relation-
ships revealed by cardiac CT were crucial for multidisciplinary decision
and allow the precise planning of the successful percutaneous closure.
In summary, this case suggests that LA perforation closure using a
percutaneous device is a feasible and safe procedure, which may con-
stitute a reasonable approach in critical patients.
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11. Goltz JP, Gorski A, Böhler J, Kickuth R, Hahn D, Ritter CO. Iatrogenic perfor-
ation of the left heart during placement of a chest drain. Diagn Interv Radiol 2011;
17:229–231.
12. Kerger H, Blaettner T, Froehlich C, Ernst J, Frietsch T, Isselhorst C. Perforation
of the left atrium by a chest tube in a patient with cardiomegaly: management of
a rare, but life-threatening complication. Resuscitation 2007;74:178–182.
13. Abbas M, Hamilton M, Yayha M, Angel D, Mwipatayi BP, Sieunarine K. A simple
method of closing an iatrogenic subclavian arterial puncture. Indian J Surg 2004;
66:356–358.
14. Hatfield MK, Zaleski GX, Kozlov D, Woo T, Gentile E, Sinnen J. Angio-Seal de-
vice used for hemostasis in the descending aorta. AJR Am J Roentgenol 2004;183:
612–614.
15. Lupattelli T, Clerissi J, Clerici G, Minnella DP, Casini A, Losa S. The efficacy and
safety of closure of brachial access using the AngioSeal closure device: experi-
ence with 161 interventions in diabetic patients with critical limb ischemia. J Vasc
Surg 2008;47:782–788.
16. Krishnasamy VP, Hagar MJ, Scher DJ, Sanogo ML, Gabriel GE, Sarin SN. Vascular
closure devices: technical tips, complications, and management. Tech Vasc Interv
Radiol 2015;18:100–112.






/ehjcr/article/4/5/1/5896118 by guest on 24 February 2021
